A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression
Public ClinicalTrials.gov record NCT00141271. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Six-Week, Randomized, Double-Blind, Multicenter, Fixed-Flexible Dose, Placebo-Controlled Study Evaluating the Efficacy and Safety of Oral Ziprasidone in Outpatients With Bipolar I Depression
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a 6-week trial that evaluates the efficacy and safety of Geodon (ziprasidone) in outpatient subjects ages 18 and older with Bipolar Disorder type I, depressed. Subjects are required to undergo a washout period of at least 7 days of any prior med.
Study identification
- NCT ID
- NCT00141271
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 536 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2005 (Type not available)
- Primary completion
- Feb 2008 (Actual)
- Completion
- Feb 2008 (Actual)
- Last update posted
- Mar 25, 2021
2005 – 2008
United States locations
- U.S. sites
- 72
- U.S. states
- 25
- U.S. cities
- 63
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Birmingham | Alabama | 35209 | — |
| Pfizer Investigational Site | Dana Point | California | 92629 | — |
| Pfizer Investigational Site | La Mesa | California | 91942 | — |
| Pfizer Investigational Site | Laguna Hills | California | 92653 | — |
| Pfizer Investigational Site | Oceanside | California | 92056 | — |
| Pfizer Investigational Site | Orange | California | 92868 | — |
| Pfizer Investigational Site | San Diego | California | 92108 | — |
| Pfizer Investigational Site | San Diego | California | 92120 | — |
| Pfizer Investigational Site | Santa Ana | California | 92705 | — |
| Pfizer Investigational Site | Torrance | California | 90505 | — |
| Pfizer Investigational Site | Fort Lauderdale | Florida | 33319 | — |
| Pfizer Investigational Site | Gainesville | Florida | 32607 | — |
| Pfizer Investigational Site | Hialeah | Florida | 33016 | — |
| Pfizer Investigational Site | Jacksonville | Florida | 32216 | — |
| Pfizer Investigational Site | North Miami | Florida | 33161 | — |
| Pfizer Investigational Site | Orlando | Florida | 32806 | — |
| Pfizer Investigational Site | Winter Park | Florida | 32789 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30308 | — |
| Pfizer Investigational Site | Maywood | Illinois | 60153 | — |
| Pfizer Investigational Site | Naperville | Illinois | 60563 | — |
| Pfizer Investigational Site | Schaumburg | Illinois | 60194 | — |
| Pfizer Investigational Site | Greenwood | Indiana | 46143 | — |
| Pfizer Investigational Site | Lafayette | Indiana | 47905 | — |
| Pfizer Investigational Site | Prarie Village | Kansas | 66206 | — |
| Pfizer Investigational Site | New Orleans | Louisiana | 70114 | — |
| Pfizer Investigational Site | Shreveport | Louisiana | 71101 | — |
| Pfizer Investigational Site | Shreveport | Louisiana | 71105 | — |
| Pfizer Investigational Site | Boston | Massachusetts | 02114 | — |
| Pfizer Investigational Site | Worcester | Massachusetts | 01605 | — |
| Pfizer Investigational Site | Minneapolis | Minnesota | 55454 | — |
| Pfizer Investigational Site | Flowood | Mississippi | 39232 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63128 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63144 | — |
| Pfizer Investigational Site | Omaha | Nebraska | 68131 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89102 | — |
| Pfizer Investigational Site | Clementon | New Jersey | 08021 | — |
| Pfizer Investigational Site | Toms River | New Jersey | 08755 | — |
| Pfizer Investigational Site | New York | New York | 10021 | — |
| Pfizer Investigational Site | Staten Island | New York | 10305 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45267-0001 | — |
| Pfizer Investigational Site | Cleveland | Ohio | 44106 | — |
| Pfizer Investigational Site | Cleveland | Ohio | 44113 | — |
| Pfizer Investigational Site | Mayfield | Ohio | 44143 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73118 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19131 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19149 | — |
| Pfizer Investigational Site | Pittsburgh | Pennsylvania | 15213 | — |
| Pfizer Investigational Site | Charleston | South Carolina | 29425 | — |
| Pfizer Investigational Site | Columbia | South Carolina | 29201 | — |
| Pfizer Investigational Site | Memphis | Tennessee | 38119 | — |
| Pfizer Investigational Site | Nashville | Tennessee | 37203-1515 | — |
| Pfizer Investigational Site | Bellaire | Texas | 77401 | — |
| Pfizer Investigational Site | Dallas | Texas | 75216 | — |
| Pfizer Investigational Site | Dallas | Texas | 75234 | — |
| Pfizer Investigational Site | DeSoto | Texas | 75115 | — |
| Pfizer Investigational Site | Galveston | Texas | 77555-0188 | — |
| Pfizer Investigational Site | Houston | Texas | 77555 | — |
| Pfizer Investigational Site | Irving | Texas | 75062 | — |
| Pfizer Investigational Site | Plano | Texas | 75093 | — |
| Pfizer Investigational Site | Richardson | Texas | 75080 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78229 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78284-7792 | — |
| Pfizer Investigational Site | Wichita Falls | Texas | 76309 | — |
| Pfizer Investigational Site | Arlington | Virginia | 22201 | — |
| Pfizer Investigational Site | Falls Church | Virginia | 22041 | — |
| Pfizer Investigational Site | Richmond | Virginia | 23229 | — |
| Pfizer Investigational Site | Richmond | Virginia | 23230 | — |
| Pfizer Investigational Site | Virginia Beach | Virginia | 23452 | — |
| Pfizer Investigational Site | Kirkland | Washington | 98033 | — |
| Pfizer Investigational Site | Milwaukee | Wisconsin | 53226 | — |
| Pfizer Investigational Site | Milwaukee | Wisconsin | 53227 | — |
| Pfizer Investigational Site | West Allis | Wisconsin | 53227 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00141271, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 25, 2021 · Synced Nov 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00141271 live on ClinicalTrials.gov.